Arjo AB (publ) (FRA:A39)

Market Cap	777.26M
Revenue (ttm)	1.05B
Net Income (ttm)	42.12M
Shares Out	n/a
EPS (ttm)	0.15
PE Ratio	18.45
Forward PE	13.02
Dividend	0.09 (3.05%)
Ex-Dividend Date	Apr 30, 2025

Volume	n/a
Average Volume	378
Open	2.852
Previous Close	2.842
Day's Range	2.852 - 2.852
52-Week Range	2.760 - 4.148
Beta	n/a
RSI	43.14
Earnings Date	Apr 29, 2025

About Arjo AB

Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia care, bariatric room solutions, prone posit...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1957
• Employees: 7,173
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: A39

Financial Performance

In 2024, Arjo AB's revenue was 11.29 billion, an increase of 2.84% compared to the previous year's 10.98 billion. Earnings were 498.00 million, an increase of 3.75%.

Financial numbers in SEK